Although PCa diagnostics have evolved, traditional methods such as digital rectal examination, prostate-specific antigen (PSA) testing, and biopsy still suffer from limitations, including patient discomfort, low specificity, and infection risk [6,7]. This evidence concerns the gene KLK3 and infection.